Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm driven by the fusion gene BCR::ABL1, which encodes a constitutively active and targetable tyrosine kinase. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.